Barcelona, Spain—New research shows that patients with primary sclerosing cholangitis (PSC) face an increased risk for certain cancers previously not known to be associated with the disease.
Swedish investigators studied data from more than 1,440 people with PSC in their country and found significantly higher rates of stomach and pancreatic cancers and lymphoma.
“The findings are surprising but we need to interpret these results with caution,” said Aline Charabaty, MD, an